Daudigeos-Dubus E - Search Results

1

Simultaneous quantification of preactivated ifosfamide derivatives and of 4-hydroxyifosfamide by high performance liquid chromatography-tandem mass spectrometry in mouse plasma and its application to a pharmacokinetic study.

Deroussent A, Skarbek C, Maury A, Chapuis H, Daudigeos-Dubus E, Le Dret L, Durand S, Couvreur P, Desmaële D, Paci A. Deroussent A, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Jun 15;992:30-5. doi: 10.1016/j.jchromb.2015.04.025. Epub 2015 Apr 20. J Chromatogr B Analyt Technol Biomed Life Sci. 2015. PMID: 25939095

2

Establishment and characterization of new orthotopic and metastatic neuroblastoma models.

Daudigeos-Dubus E, LE Dret L, Rouffiac V, Bawa O, Leguerney I, Opolon P, Vassal G, Geoerger B. Daudigeos-Dubus E, et al. In Vivo. 2014 Jul-Aug;28(4):425-34. In Vivo. 2014. PMID: 24982206

3

Iron Overload Exacerbates Busulfan-Melphalan Toxicity Through a Pharmacodynamic Interaction in Mice.

Bouligand J, Richard C, Valteau-Couanet D, Orear C, Mercier L, Kessari R, Simonnard N, Munier F, Daudigeos-Dubus E, Tou B, Opolon P, Deroussent A, Paci A, Vassal G. Bouligand J, et al. Among authors: daudigeos dubus e. Pharm Res. 2016 Aug;33(8):1913-22. doi: 10.1007/s11095-016-1927-z. Epub 2016 Apr 18. Pharm Res. 2016. PMID: 27091031

4

Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models.

Daudigeos-Dubus E, Le Dret L, Lanvers-Kaminsky C, Bawa O, Opolon P, Vievard A, Villa I, Pagès M, Bosq J, Vassal G, Zopf D, Geoerger B. Daudigeos-Dubus E, et al. PLoS One. 2015 Nov 23;10(11):e0142612. doi: 10.1371/journal.pone.0142612. eCollection 2015. PLoS One. 2015. PMID: 26599335 Free PMC article.

5

Dual inhibition using cabozantinib overcomes HGF/MET signaling mediated resistance to pan-VEGFR inhibition in orthotopic and metastatic neuroblastoma tumors.

Daudigeos-Dubus E, Le Dret L, Bawa O, Opolon P, Vievard A, Villa I, Bosq J, Vassal G, Geoerger B. Daudigeos-Dubus E, et al. Int J Oncol. 2017 Jan;50(1):203-211. doi: 10.3892/ijo.2016.3792. Epub 2016 Dec 6. Int J Oncol. 2017. PMID: 27922668

6

Polo-like Kinase Inhibitor Volasertib Exhibits Antitumor Activity and Synergy with Vincristine in Pediatric Malignancies.

Abbou S, Lanvers-Kaminsky C, Daudigeos-Dubus E, LE Dret L, Laplace-Builhe C, Molenaar J, Vassal G, Geoerger B; within the ITCC Biology and Preclinical Evaluation Committee. Abbou S, et al. Among authors: daudigeos dubus e. Anticancer Res. 2016 Feb;36(2):599-609. Anticancer Res. 2016. PMID: 26851014

7

Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice.

Marques da Costa ME, Daudigeos-Dubus E, Gomez-Brouchet A, Bawa O, Rouffiac V, Serra M, Scotlandi K, Santos C, Geoerger B, Gaspar N. Marques da Costa ME, et al. Among authors: daudigeos dubus e. Cancer Med. 2018 Mar;7(3):665-676. doi: 10.1002/cam4.1346. Epub 2018 Feb 23. Cancer Med. 2018. PMID: 29473324 Free PMC article.

8

Anti-insulin-like growth factor 1 receptor antibody EM164 (murine AVE1642) exhibits anti-tumour activity alone and in combination with temozolomide against neuroblastoma.

Geoerger B, Brasme JF, Daudigeos-Dubus E, Opolon P, Venot C, Debussche L, Vrignaud P, Vassal G. Geoerger B, et al. Eur J Cancer. 2010 Dec;46(18):3251-62. doi: 10.1016/j.ejca.2010.06.005. Epub 2010 Jun 28. Eur J Cancer. 2010. PMID: 20591650

9

The selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor activity in human neuroblastoma xenografts.

Rössler J, Monnet Y, Farace F, Opolon P, Daudigeos-Dubus E, Bourredjem A, Vassal G, Geoerger B. Rössler J, et al. Int J Cancer. 2011 Jun 1;128(11):2748-58. doi: 10.1002/ijc.25611. Epub 2010 Oct 8. Int J Cancer. 2011. PMID: 20715103

10

Inhibition of the NOTCH pathway using γ-secretase inhibitor RO4929097 has limited antitumor activity in established glial tumors.

Dantas-Barbosa C, Bergthold G, Daudigeos-Dubus E, Blockus H, Boylan JF, Ferreira C, Puget S, Abely M, Vassal G, Grill J, Geoerger B. Dantas-Barbosa C, et al. Anticancer Drugs. 2015 Mar;26(3):272-83. doi: 10.1097/CAD.0000000000000190. Anticancer Drugs. 2015. PMID: 25486598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters